Deferoxamine inhibition of malaria is independent of host iron status by unknown
Iron plays a central role in a number of essential biochemical reactions. Since
iron deprivation in microbial cultures is regularly associated with inhibition ofgrowth,
it has been suggested that hypoferremia may represent an important defense mech-
anism (1, 2). A number of clinical observations have suggested that iron deficiency
may have a beneficial effect in human malaria, and that conversely, iron administra-
tion may aggravate malaria (3-5). Likewise, deferoxamine (DF)t, a siderophore
useful in the management of iron overload, inhibits the in vitro growth of Plasmo-
diumfalciparum (6, 7) and in vivo malarial infection in several species of mammals
(8, 9). The DFiron complex, however, is not inhibitory(6, 8). The aim ofthe present
study was to define the mechanism by which DF inhibits malarial infection. In par-
ticular, we wished to determine whether this was caused by the induction of iron
deficiency in the host, analogous with clinical iron deficiency, or by direct interfer-
ence with the acquisition of intracellular iron. Our results indicate that the in vivo
suppression of malaria by DF is independent of host iron status and suggest that
interaction with chelatable iron in parasitized erythrocytes may be responsible for
the inhibition of infection.
Rats
Female Wistar rats (supplied by Harlen-Olac Ltd., Bicester, Oxon, England) weighing
140-150 g were housed in groups of 4-6 in plastic cages with stainless steel grid lids and fed
ad lib with RNM3 food (S. D. S., Witham, Essex, England). Blood samplings and injections
of "Fe were performed through the tail veins. Animals were killed by ether anesthesia or
by exsanguination through the abdominal aorta under ether anesthesia.
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Groups of 12-40 rats were infected with a standard inoculum (N3 x 10') of Plasmodium
berghei (ANKA strain, donated by Dr. Jarra, National Institute of Medical Research, Mill
Hill, UK) diluted in 1 ml RPMI and injected via two intraperitoneal injections. Parasitemias
were estimated by counting at least500 cells in methanol-fixed, Giemsa-stained bloodfilms.
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Materials and Methods
In vivo radioiron labeling was performed by diluting "FeCl3 (sp act, 3-20 pCi/pg, Amer-
sham International, Amersham, UK) prepared in 0.005 N HCl and mixed with sufficient
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sterile 4% sodium citrate to ensure a molar ratio of citrate to iron in excess of 50:1, to a final
concentration of 1 or 25 WCi/ml . 1 ml ofthis solution was injected through the tail vein under
light ether anesthesia. For the measurement ofwhole blood radioactivity, 50-ul tail vein samples
were collected on alternate days and diluted to 1 ml before counting . The radioactivity of
spleen, kidney, weighed portions of the liver, and the diluted blood samples was determined
in an automatic gamma counter (model 1282, Pharmacia LKB, Bromma, Sweden) . Whole
body counts were performed in a Shadow Shield-type total body counter (10) and results
were expressed as percent of day 0 radioactivity in the same animal, corrected for 59Fe decay.
In preliminary studies using "Cr-labeled erythrocytes (11, 12), blood volume was found to
be 6.4 ml per 100 gbody weight, and the proportion ofcirculating blood radioactivity trapped
in the liver was 2.4% . These factors were used in subsequent studies to calculate net hepatic
and total blood radioactivity. Residual tissue radioactivity was calculated from total body ac-
tivity minus the combined radioactivity of liver, spleen, blood, and kidney.
Serum iron and total iron binding capacity were determined by theICSH Iron Panel method
(13). Total non-heme iron was determined by the method ofTorrance and Bothwell (14) . Blood
counts and mean corpuscular volume (MCV) measurements were performed in model S +
IV counter (Coulter Electronics Inc ., Hialeah, FL) with histogram differential . Reticulocytes
were estimated by counting 1,000 RBC stained supravitally with brilliant cresyl blue .
Therapeutic Interventions
Deferoxamine Treatment.
￿
Deferoxamine (Ciba, Zurich, Switzerland) was freshly dissolved
in distilled water and diluted in sterile isotonic saline to provide a final concentration of 50
mg/ml or dilutions thereofas specified in Results . Unless otherwise specified, doses of 1 mg/g
body weight per day were administered by subcutaneous injections divided into three daily
doses given at 8-h intervals . Injections were started on the day of malaria inoculation (day
0) and continued throughout . In studies in which DF treatment was started on day 7 or 12,
the same dose was administered by continuous infusion through a subcutaneous pediatric
set secured to the forehead for 3 d and continued thereafter by three daily injections until
the end of the study.
Iron Depletion .
￿
This was produced by raising 3 wk old weanling rats (50 t 5 g) on an
RM3 Low Iron Diet (S. D. S.) supplied ad lib. This diet is based on skimmed milk powder,
sugar, and soybean oil, and has an iron content of 7 ppm . The amounts of other trace metals
(ppm) and vitamins (mg/kg) were as follows : Cu, 7 ; Mn, 3 ; Zn, 67 ; Co, 45 ; Se, 6 ; vitamin
B1, 1.95 ; B2, 26.0 ; B6, 2.6 ; Folate, 0.39 ; Niacin, 6.5; Pantothenic a., 22 .8 ; Retinol, 59 ; Cal-
ciferol, 6 ; and Tocopherol, 6 . The food was supplemented with 100 mg/kg of paraminoben-
zoic acid . Control animals of the same weanling cohort were raised on the same diet, sup-
plemented with 144 ppm iron . Studies were begun after 22 d on the special diets, by which
time the control and iron-deficient animals weighed 140 t 7 and 127 f 4 g, respectively.
The effect of the iron-deficient diet on the experimental group was monitored by measure-
ment of serum iron and transferrin saturation. Iron deficiency was confirmed by the develop-
ment of a microcytic hypochromic anemia (see Table II) .
Iron Loading .
￿
This was produced by the injection of ferric citrate at a dose representing
7.5 mg/kg elemental iron per day, intraperitoneally, starting on day 0 for 10 consecutive days .
Previous studies by Awai et al. (15) have shown that this is the highest dose tolerated for the
parenteral injection of a soluble iron salt, and that a single injection will produce serum iron
levels exceeding the total iron binding capacity of the plasma for ti4 h .
Studies on Intracellular Iron
Preparation ofCells.
￿
Rats, with parasitemias ofat least 25%, were injected intraperitoneally
with 25 gCi 59Fe-citrate and bled 16 h later . When indicated, whole blood was incubated in
9 vol ofRPMI 1640 containing 4 g/liter glucose, 2 g/liter NaHC03, 2mM glutamine, 37.5%
Hepes in an atmosphere of5% Os, 7% COs in nitrogen at 37°C . No cell lysis was observed
during the incubation period .
Preparation of Cell Lysates.
￿
Cells were washed four times (500 ,g for 10 min) in PBS and
0.5 ml aliquots resuspended in 2 ml PBS . Cells were lysed by sonication (5 for 1 s), 10%
Triton X-100 was then added to give a final concentration of 1%, and they were centrifugedHERSHKO AND PETO
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at 10,000 g for 15 min . The, pellet contained <10% of the total radioactive counts . Prelimi-
nary experiments showed that freezing supernatants resulted in precipitation ofhemoglobin,
while storage of intact cells at 4°C for up to 48 h did not alter the results. Supernatants were
analyzed immediately.
Interaction of reticulocyte iron with DF was tested in two phases . DF was first incubated
with washed, intact, radioiron-labeled cells at various concentrations, as specified in Table
III, to assess the ability ofDF to penetrate the cells . Afterthe incubation and cell lysis, lysates
were divided. 3mM DF was added to one aliquot in order to measure total chelatable iron .
The other aliquot was used to measure the fraction of chelatable iron generated in intact
reticulocytes .
GelFiltration.
￿
Supernatants were analyzed by gel filtration (UltrogelACA-34 column [40
cm x 9.0 cm 2 1 equilibrated with 0 .1mM Tris, pH 7.6, Pharmacia LKB). The radioactivity
of 1.2-ml fractions was determined. The column was precalibrated with blue-dextran, fer-
ritin, hemoglobin, and dinitrophenol .
Ultrafiltration .
￿
Supernatants (1.5 ml) were also subjected to ultrafiltration using Centricon
30 filters (Amicon Corp ., Danvers, MA ; mol wt exclusion limit, 30 kD) by centrifugation
(fixed rotor) at 5,000g for 20 min according to the manufacturer's instructions. Filtered volumes
ranged from 0.25-0.7 ml but were uniform withineach batch ofresults. Comparison offiltered
volumes obtained with Centricon 30 and 10 (exclusion limit, 10 kD) showed greater filtrate
volumes using Centricon 30, but no increase in total filtratable radioactivity. Radioactivity
in the filtrate was counted for 30 min and the total filtrable S9Fe calculatedby using a volume
correction.
Statistics .
￿
As parasite counts varied widely, a non-parametric test (Wilcoxin-rank) was used
to confirm differences at the peak day of infection. Errors of radioactivity counts for the esti-
mates of filtratable "Fe were calculated from the Poissonian distribution according to the
total number of radioactive counts detected .
Results
Effect ofDF on Parasite Counts
Fig . 1 A shows the peripheral blood parasite counts from a representative study
of six treated rats, receiving 1 mg/g DF per day, subcutaneously, starting on the
day of inoculation, and five untreated controls. Fig. 1 B shows the composite data
from three studies of peak parasitemias in a total of 15DFtreated rats and 14 con-
trols. Peak parasitemia in untreated controls was reached on days 11-14 after inocu-
lation, and ranged from 52-663 infected cells per 1,000 RBC . In contrast, inDF
treated animals, peak parasitemia was reached on days 4-10 and ranged from 6-40
per 1,000RBC . Untilday 6-7, therewas no discernible difference in the parasitemia
between the control and DFtreated group. By day 10 and after, the difference in
parasite counts in the two groups was significant (p < 0.01) .
To examine the effects ofDF dose on parasite growth in vivo, the results of DF
1 mg/g per day were compared with 0.5, 0.25, and 0.125 mg/g per day in groups
of eight animals . Two of the animals receiving DF 1 mg/g per day died ofdrug tox-
icity manifested in stunted growth and cachexia, with parasite counts of 1 .1 and 1.4% .
Peak parasitemia (geometric means) in the untreated group was 18.770 compared
with 2.6, 1.9, 3 .4, and 2.1% in the 1.0, 0.5, 0.25, and 0.125 mg/g per day groups,
respectively. In comparison with untreated controls, all doses were effective (p < 0.01)
in suppressing infection, and no difference in efficacy between the doses was ob-
served . In contrast, no suppressive effect couldbe seen when DF treatment (1 mg/g
per day) given by continuous infusion was started on day 7 (n = 4) or 12 (n = 6)
of the infection as judged by daily parasite counts and mortality .378
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FIGURE 1 .
￿
(A) Individual parasitecounts in control
and DRtreated rats . DF discontinued on day 19.
Counts between days 19 and 28 did not exceed 0.01%
in either group. (B) Combinedresults ofthreestudies
representing peak parasitemia in individual rats .
Effect ofDFand Malaria on Host Iron Status
To examine the effect ofDF treatment on host iron status, four groups of 5-6
rats were divided into thosereceiving(a)no treatment(normal) ; (b)DF only (normal
+ DF); (c) malaria; or (d)malaria + DE 24h before inoculation (day -1) all animals
were given 1 wg"Fe-ferric citrate by intravenous injection. Groups (c) and (d) were
infected on day 0. All animals were killed on day 12 . Results of these experiments
are presented in Table I and Fig . 2.
The effect of DF treatment on normal animals is shown by the comparison of
the first two experimental groups (a and b) . There was a marked reduction in body
weight but there was no effect on hemoglobin concentration, MCV, numbers of
reticulocytes, serum iron level, or transferrin saturation . Hepaticnon-heme ironwas
reduced by 56%. There was a marked effect ofDF on total body radioactivity, with
excretion of 25% of the injected 59Fe in excess of spontaneous excretion in untreated
controls . Asshown by the organradioactivity onday 12, this excretionwasrecruited
from hepatic and residual iron stores, whereas blood radioactivity was unaffected
by DF treatment .
The effect ofP . berghei infection on iron status is shown by comparison of groups
a and c. Infection resulted in stunted growth and a striking increase in splenic size
(4.55 vs . 0.41 g) . Byday 12, all infected animalshad severe anemia with an increase
inMCVand reticulocytosis. The increase inMCVwas thecomposite effect of sur-
viving old RBC with an MCV of 56 fl and the emergence ofyoung RBC with an
MCV of -100 fl . Transferrin saturation was slightly increased, but there was no
significant increase in hepatic non-heme iron . The percent reduction in blood 59FeHERSHKO AND PETO
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TABLE I
Effect ofDF andMalaria on Host Iron Status
(a)
￿
(b)
￿
(c)
￿
(d)
Normal
￿
Normal + DF
￿
Malaria
￿
Malaria + DF
Day 0
Weight (g) : Body
￿
140.0 t 7.4
￿
137 .0 t 4.1
￿
137.0 t 3 .0
￿
141 .0 t 3.7
Day 12
was identical to the reduction in hematocrits, indicating equal destruction ofyoung
(59Fe-labeled) and old, unlabeled erythrocytes. The loss of blood radioactivity is ac-
counted for by a simultaneous increase in hepatic and splenic radioactivity . The lack
of increase in spontaneous 59Fe excretion and low kidney radioactivity exclude
significant hemoglobinuria associated with the severe hemolysis .
DF treatment in infected animals (group d), had a dual effect . On one hand it
suppressed the manifestations of the infectious process . Thus, splenomegaly, anemia,
and all secondary effects of hemolysis such as reticulocytosis, increased MCV re-
duced blood radioactivity, and reciprocal 59Fe accumulation in spleen and liver were
less pronounced in the DF-treated group. On the other hand, it promoted iron ex-
cretion . Thus, all the effects ofDF observed in normal animals, such as increased
radioiron excretion and reduced storage iron documented both by "Fe and non-
heme iron measurements, could be discerned in infected animals as well . Compar-
ison ofgroups band d reveals that malaria did not alterthe magnitude of these changes.
The suppressive effect ofDF on malaria was achieved withoutany reduction in trans-
ferrin saturation or interference with hemoglobin production, and withonly a moderate
effect on hepatic non-heme iron stores .
Effect of Host Iron Status on Malaria .
The putative effect ofhost iron status on the rate ofmalaria progression was studied
by the induction of iron deficiency or iron overload .
Weight (g) : Body
Liver
Spleen
159.0 t 9.1
6.6 t 0.5
0.4 t 0.03
132.0 t 14 .2
5.7 t 1 .1
0.5 t 0.2
140.6 t 7 .1
7.6 t 1 .0
4.6 t 0.4
135.0 t 2.2
7.5 t 1 .0
2.0 f 0.3
Parasitemia - - 32 .1 t 14.9 0.13 t 0.1
Iron status
Hb 13.5 t 0.9 14 .3 t 1 .2 5.2 t 1 .4 8.2 t 0.5
HCT 37 .1 t 1 .8 39 .2 t 3.1 16.8 t 2.8 22 .7 f 1 .5
MCV 56.3 f 1 .0 55 .2 t 0.7 85.5 t 14.2 59.8 t 2.8
Retics(%) 2.710.5 2.010.9 46.31 13.4 11.4 5.1
Se Fe (gM) 55.7 t 8.3 76.0 t 14 .1 59 .1 t 14.4 84.8 t 26.2
TIBC (NM) 84.6 t 8.9 92 .7 t 11 .6 76.5 t 23 .1 117.8 t 9.9
Saturation (0 /6) 65 .6 t 3.6 82.3 t 12.9 81.0 t 22.2 71.0 t 0.2
Liver Fe (wg) 1,237 t 191.1 544.4 t 44 .5 1,327.5 t 82.8 671.4 t 47 .1
(%) Organ distribution 59Fe
Blood 54.5 t 7 .7 56.2 t 11 .5 17.7 t 5.7 31.0 t 2.0
Liver 18 .1 t 2.0 3.7 t 1 .0 28.6 t 1 .6 7.1 t 0.8
Spleen 0.8 t 0.1 0.8 t 0.3 17.8 t 3.7 7.8 f 1 .1
Kidney 1 .3 t 0.2 1 .0 t 0.4 1.7 t 0.5 0.5 * 0.1
Residual 12 .9 t 7 .1 0 t 4.0 18.3 t 2.7 12.4 t 1.8
Excretion 13.8 t 2 .1 38.3 t 2.8 15.9 t 2.5 41.2 t 1 .1380
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TABLE II
Effects of Iron Deficiency
FIGURE 2.
￿
Mean parasitemia (geometric), whole
body S9Fe andblood "Fe counts (mean t 1 SD
in DF-treated and control animals. For identifica-
tion of groups see Table I .
Iron Deficiency.
￿
Table II documents the severity of iron deficiency in weanlings
raised on an iron-deficient diet (iron, 7 ppm) for 22 d, compared with controls raised
on the same diet supplemented with iron at 140ppm. The hematocrit, MCV, and
body weight on day 0 and 10 of the study were all significantly lower in the iron-
Control
￿
Iron Deficient
Day 0
Weight (g): Body
Reticulocytes (%a)
Hematocrit
MCV
144.0 t 7
4.4 t 0.3
46 .4 * 1.7
59 .6 t 1 .3
127 .0 t 4.4
3.2 t 1 .1
24 .7 t 5.7
54.0 t 2.9
Day 7
Reticulocytes (%) 6.9 t 2 .4 26.7 t 20 .3
Day 10
Hematocrit 17 .8 t 3 .6 9.7 t 1 .4
Hb (gldl) 5 .3 t 0 .9 3.2 t 0.3
MCV (fl) 94 .7 t 7.8 67.8 t 2.7
Serum Fe (pM) 90 .6 t 22.2 14.9 t 3.7
TIBC (kM) 95.4 t 24 88.5 t 11 .5
Saturation (%) 96 .1 t 2.3 17.3 t 5.9
Parasitaemia (%) 35 .7 30.0
Deaths 0 2HERSHKO AND PETO
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FIGURE 3 . Mean parasitemia in two
studies comparing (A) chronic iron defi-
ciency and (B) acute iron loading with
ferric citrate with the corresponding con-
trol groups .
deficient group . In spite of the hemolysis associated with malaria and manifested
in the further aggravation of anemia, transferrin saturation in iron-deficient rats at
the conclusion ofthe study was only 17% compared with 96% in the control group .
Throughout the entire study, iron-deficient rats had higher parasite counts when
expressed as percent infected RBC (Fig . 3 A) . However, this difference is not cor-
rected for the lower red cell counts in the anemic iron-deficient group. Peak parasitemia
on the last day of study was nearly identical in both groups .
Iron Loading .
￿
This was achieved by daily intraperitoneal injections of7.5mg iron/kg
supplied as ferric citrate, on 10 consecutive days startingon day 0 . Asshown in Fig .
3 B, iron loading to a cumulative dose representing eight times the hepatic iron stores
ofnormal rats, had no effect on the timing or magnitude of parasite counts com-
pared with normal controls .
Effect ofDF on Parasitized Reticulocytes
Since host iron statuswas largely unaffected by therapeutic doses of DF, whereas
gross variations in iron status induced by other means had no effect on the progres-
sion ofmalaria, we examined the possibility that DFmay interact directly with chelat-
able iron in parasitized erythrocytes . The putative existence of chelatable iron was
investigated by gel filtration of hemolysates obtained from parasitized erythrocytes
labeled in vivo by the intravenous injection of "Fe-citrate 16 h previously . The
hemolysate was preincubated with 70 ttM DF before separation on Ultrogel ACA-
34 columns in order to prevent the retention of loosely bound chelatable iron on
thecolumn . As shown in Fig . 4 A, in addition to amajor peak oflabeled hemoglobin
(84.5%), the existence of a void volume fraction (5.8%), ferritin (7.7%), and a low
molecular weight radioiron complex (2.0%) could be demonstrated in parasitized
erythrocytes. Control experiments showed thatDFtreated lysates prepared from unin-
fected cells, radiolabeled 6 d previously, only showed a single hemoglobin peak .382
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FIGURE 4 .
￿
Gel filtration (Ultrogel ACA-34) of
lysates obtained from parasitizedRBC labeled in
vivo with "Fe 16 h previously . The major peak
represents hemoglobin . Arrows indicate void
volume (vol/vol), and positions offerritin (Fern)
and low molecular weight (Low MM peaks .
Deferoxamine (DF, 70 WM) wasadded to the ly-
sate beforegel filtration (A) or to thecolumnafter
the elution of the hemoglobin peak (B) . (B)
Dinitrophenol (DNPL) was added as a low
molecular weight marker first to the lysate, and
second withDE The total radioactivity ofthely-
sate was 53,000 (A)and in 118,000cpm (B) . Total
recovery in the eluates was95.5 and91.0%, respec-
tively .
To distinguish between labile iron present a priori in parasitized reticulocytes or
produced in vitro by the interaction ofDF with either ferritin ofhemoglobin iron,
the lysate was subjected to chromatography without preincubation withDR As shown
in Fig . 4 B, only the labeled void volume fraction, ferritin, and hemoglobin were
eluted initially from the Ultrogel column . However, subsequent washing with 70
pM ofDF resulted in the elution ofa chelated radioiron fraction similar to that de-
scribed in Fig . 4A, representing chelatable iron retained temporarily on thecolumn .
This finding proves that the labile iron is not derived from the in vitro interaction
of DF with ferritin or hemoglobin iron, since neither has been exposed to DF at
any time, and supports the a priori existence of a chelatable, labile iron pool in parasi-
tized reticulocytes .
To study further the interaction between labeled parasitized reticulocytes and DR,
a simplified method was used using Amicon filters that retain molecules >30,000
daltons . Table III describes the effect ofDF incubation on the magnitude of the chelated
and chelatable radioiron fraction asmeasured byAmicon filtration . Both increasing
the concentration or increasing the time ofDF incubation resulted in an increased
efficiency of radioiron chelation in intact cells . Conversely, there was less radioiron
remaining in the cell lysate for additional chelation. Sinceno radioiron was present
in the incubation medium, the gradual increase with time in total chelatable iron
implies the generation of chelatable iron from an existing intracellular 59Fe pool .
We found no evidence for the release of chelated intracellular iron into the incuba-
tion medium .
Toshow thatDF was able to interact in vivo with labile intracellular iron, 0.3 mglg
of DF was injected subcutaneously 2 h before killing an infected animal (45%
parasitemia) labeled 16 h previously with 59Fe. The fraction offiltratable iron found
in the radiolabeled cellswas 0.55% compared with a total chelatable fraction of 1.1% .All incubations for 180 min.
$ All incubations with 600 gM DF .
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TABLE III
Effects ofDF Concentration and Time on the Amount of Iron Clulated in Parasatized RBC
Percent of total 59Fe at DF concentration (WM) of :'
Intact RBC
Lysate
Total
Percent of total 59Fe at DF treatment duration (min) of:t
Intact RBC
Lysate
Total
Discussion
It has been suggested that iron deprivation is an important defense mechanism
limiting the growth of invading organisms (1, 2) . Anumber ofclinical observations
suggestthat iron administration may aggravatethe risk associated with malarial in-
fection (3-5). The relative shortage ofintracellular hemoglobin in iron-deficient RBC
maybe responsible forlimiting parasite growth (16) . Clinical evidence, however, for
the protective effect of iron deficiency or the deleterious effect of iron supplementa-
tion in human malaria is not conclusive (17, 18).
In view ofthe possible beneficial effects of iron depletion, DF, a siderophore that
binds iron with an affinity of 103'M-1 , has been studied as a possible antimalarial
agent . DF inhibits the growth ofP . falciparum cultured in vitro at a concentration
of 15 pM (6), possibly by interfering with the acquisition of iron from transferrin
(19, 20). Other studies have confirmed the in vitro inhibition ofP . falciparum by DF,
buthave failed to demonstratetheuptake oftransferrin ironby the parasitized RBC,
or theinhibition of parasite growthby the removal ofiron from theculture medium
(7) . The present study demonstrates that DF, given every 8 h suppresses P . berghei
infections in rats, andrecent similar studies onmice withP . vinckei(8) andon monkeys
withP . falciparum (9) have shown that it is possible to suppress malarial infection
in vivo by the continuous supply of DF, usingimplantedsubcutaneous osmotic pumps
or frequent daily injections. The failure of single daily injections to suppress infec-
tion, showninour preliminary studies and in those ofFritch et al . (8), demonstrates
that continuous exposure to the drug is essential .
In the present study, we have attempted to define the site of action ofDE As an
iron chelator, DF might inhibit malaria in vivo by two mechanisms ; firstly, by the
induction of iron deficiency, which will limit the amount of iron available to the
parasite by reducing plasma transferrin iron or intracellularhemoglobin; or secondly,
by direct interference with the acquisition of intracellular iron by the parasite. We
elected to study these questions in the rat because iron requirements and the in-
ternal recycling of iron in this specieshave been characterized in great detail in previous
studies (11, 12) .
The present data clearly show that the therapeutic in vivo effect of DF cannot
0 50 200 500
0.06 t 0.01 0.33 t 0.01 0.76 t 0.02 1 .07 t 0.02
0.74 t 0.02 0.73 t 0.02 0.60 t 0.03 0.39 t 0.03
0.80 t 0.02 1.06 t 0.02 1.36 t 0.02 1 .46 t 0.03
10 50 140 330
0.59 t 0.03 1 .14 t 0.03 1.28 t 0.03 1 .86 t 0.03
0.71 t 0.03 0.1 t 0.05 0.47 t 0.07 0
1.30 t 0.04 1.24 t 0.03 1.75 t 0.04 1 .86 t 0.03384
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beattributed to theinduction ofan iron-deficient statein thehost. Serum iron, trans-
ferrin saturation, hemoglobin production, and red cellindices remainedunchanged
after 12 d ofcontinuous DF treatment at doses exceeding eight times the minimal
daily dose required to suppress malaria infection in vivo. These findings exclude
the possibility that DF inhibition of malaria is achieved by reducing the amount
of available plasma iron or intracellular hemoglobin. Further evidence against the
relevance ofhost iron status forin vivo malaria proliferation has been provided by
our studies in iron-deficient and iron-loaded animals, showing no effect on death
rates or parasite counts. These findings appear to conflict with those of Harvey et
al. (21) who found a mild, protective effect of iron deficiency in mice infected by
P . chabaudi. Howeverin that study, the iron deficientdiet was started only 3 d before
infection, and no data were provided to document iron deficiency.
By exclusion, therefore, the most likely explanation for the in vivo therapeutic
effect ofDF is a direct interaction with the parasitized erythrocyte. This possibility
is supported bytheabilityofDFto inhibitthe invitrogrowth ofmalaria irrespective
of extracellular iron concentrations (7); the rapidity with which very low doses of
DF are able to inhibit in vivo malaria in monkeys (9) and the rapid rebound rise
in parasitemia in mice after the withdrawal of DF (8). If DF acts by depriving the
parasite ofintracellular iron, it follows that achelatablepool ofiron exists in parasi-
tized erythrocytes, and that DF must be able to penetrate RBC.
In mature erythrocytes, practically all iron is hemoglobin bound and therefore
not available for chelation. In contrast, in erythroblasts and reticulocytes, in which
hemoglobin synthesis is still active, there is a continuous uptake ofiron by internal-
ization ofthe transferrin-transferrin-receptor complex (22). Evidence supporting the
existenceofalowmolecularweight intracellular ironpoolhas been reviewedbyJacobs
(23). Such a pool functions as an intermediate between extracellular iron and the
intracellular iron-containing proteins. Although the exact chemical nature of the
poolisunknown, it should allbe availablefor DF chelation. In reticulocytes, several
distinct patterns of interaction between iron-chelating drugs and the intracellular
chelatable pool have been identified. Some chelators, such as EDTA, are unable to
enterthe cells. Others, such as pyridoxalisonicotinoylhydrazone (PIH), readilyenter
reticulocytes, and the chelated iron complex is extruded by an energy-dependent
process (24). Finally, some very potent chelators such as N,N'-ethylenebis(o-hy-
droxyphenyiglycine) readily chelate intracellular iron, but the chelated complex is
unable tocrossthecellular membrane and accumulateswithin thecell(25). DF shows
only a limited uptake by normal reticulocytes, and such iron as is chelated by DF
intracellularly isunable subsequently to leavethe cell(25). However, parasitizedRBC
are, in general, more permeable to malaricidal metal-chelating drugs than healthy
reticulocytes (26, 27), and the uptake of DF by parasitized erythrocytes has been
directly demonstrated in a recent study using 14C-deferoxamine (28).
Results ofthe present study extend the observations onthe interactionofDFwith
intact reticulocytesto parasitized RBC. Our studiesofinvivolabeledheavilyparasi-
tized reticulocytes indicate that -1-20 /o of the total "Fe is located in a chelatable
iron fraction, which, similar to the labile iron pool found in cultured Chang cells
(23), is retained on gel filtration columns but can readily be eluted by DF With
increasing concentrations ofextracellularDF orwith increasing duration ofincuba-
tion, a proportionately greater part of the available iron in intact reticulocytes isHERSHKO AND PETO
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chelated byDF until little or no additional chelation is achieved by subsequent incu-
bation of the lysate with a huge excess of added DR These findings confirm that
DF is able to penetrate parasitized reticulocytesand indicate that it can interact with
a chelatable iron pool . As shown in our study, the chelatable iron ofparasitized reticulo-
cytes is available for interaction with DF both in vivo and in vitro .
The design of these studies does not permit any conclusion as to the origin of
this iron pool in parasitized erythrocytes . Since P . berghei is a reticulocyte-seeking
parasite, it is possible that the chelatable iron is derived from the continued uptake
of transferrin iron by these reticulocytes, or by putative transferrin-receptor syn-
thesised in mature parasitized RBC (29-31) . The present study, however, showed
a gradual increase with time in the fraction of labeled chelatable iron in the absence
of measurable extracellular'Fe, indicating the generation of chelatable iron from
an existing intracellularpool . The pool is likely to be derived from hemoglobin; malarial
parasites exert oxidant stress on the host erythrocyte (32-34) and it has recently been
shown by Gutteridge (35) that H202 and other peroxides are able to release iron
from hemoglobin by oxidative degradation .
Although our study provides evidence for the direct interaction ofDF with a chelat-
able iron pool in the parasitized reticulocyte, it yields little information on themanner
in which this may result in the inhibition of parasite proliferation. We have shown
that the suppressive effect ofDF only occurred after 5 d or more ofcontinuous treat-
ment and could not be shown at all if treatment was started after 7 d of infection .
This slow rate of action may reflect, as already discussed, the limited ability ofDF
to penetrate erythrocytes . Low concentrations ofDF may be inadequate to compete
with the increasingamounts of intracellular iron associated with the increasing im-
maturity of reticulocytes found in the terminal phase ofinfection . Alternatively, in-
tracellular iron chelation itselfmay only exert a slow parasiticidal effect . Some an-
timalarial iron chelators, such as 8-hydroxyquinoline, are parasiticidal by forming
an extracellular complex with iron that is subsequently internalized to produce a
rapidly lethal intracellular reaction (26, 36) . Othercompounds, such as rhodotorulic
acid, mycobactin, and probably DF, exert their antimalarial effect through the depri-
vation of intracellular iron from the parasite. The iron requirements of the parasite
is at present unknown .
Studies of the mechanisms of the parasiticidal effects ofDF may have important
implications for the pathophysiology of malaria and the development ofnew strate-
gies for antimalarial therapy. In spite of the effectiveness ofDF in suppressing malaria
in experimental animals, it is unlikely that it will be suitable for the management
of clinical malaria . Its poor oral absorption, high price, and relatively slow rate of
red cell penetration make it an unlikely candidate for clinical use . However, a new
generation of orally effective iron chelators are already available (25), and explora-
tion of their antimalarial efficacy is one ofthe obvious objectives of future research .
Summary
The mechanism whereby deferoxamine (DF) inhibits the growth ofmalaria para-
sites was studied in rats infected with Plasmodium berghei . Peak parasitemia was 32.6%
(day 14) in untreated controls and 0.15% (day 7) in rats receiving 0.33 mg/g in 8
hourlyDF injections, subcutaneously. DF inhibition of parasite growth was achieved
without any reduction in transferrin saturation or hemoglobin synthesis and with386
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only a partial (56%) depletion ofhepatic iron stores . Dietary iron depletion resulted
in anemia (hematocrit 25 vs . 46%), microcytosis (MCV 54 vs . 60 fl), and reduced
transferrin saturation (17 vs . 96%) without any effect on infection (peak parasiternia
30 vs . 36%) . Similarly, parenteral iron loading with ferric citrate over 10 d (75 mg
iron/kg) failed to aggravate infection . In a search for evidence of direct interaction
between DF and parasitized erythrocytes, gel filtration and ultrafiltration was per-
formed on hemolysates obtained from in vivo "Fe-labeled parasitized erythrocytes .
This showed that 1.1-1.9% of the intracellular radioiron was located in a chelatable,
labile iron pool . Incubation of intact cells with 0-500 gM DF resulted in a propor-
tional increase in intracellular iron chelation, and the chelation ofall available labile
intracellular iron was completed within 6 h . These observations indicate that the
severity ofP . berghei infection in rats and its in vivo suppression by DF are indepen-
dent of host iron status and suggest that DF inhibition of malaria involves intracel-
lular chelation of a labile iron pool in parasitized erythrocytes .
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